Heron Therapeutics enters manufacturing/supply deal with Patheon, commits to 38,400 kg through 2026

HERON THERAPEUTICS, INC. /DE/

Framework Agreement with Patheon Austria GmbH & Co KG, a Thermo Fisher unit, for manufacturing and supply of products.
Heron commits to purchase 38,400 kg of Products through December 31, 2026.
Prior agreements terminated; obligations replaced under amended Manufacturing and Supply Agreement.
Patheon to continue stability studies and provide warehousing services for the Products.

item 1.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.